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Letters to the Editor
Red Cell Disorders
Mature erythrocyte indices: new markers of iron
availability
This study was aimed at evaluating mature ery-
throcyte indices as new markers of iron status.
Contrarily to those in the whole red blood cell
(RBC) population, mature erythrocyte parameters
are valid markers of iron status that remain inde-
pendent of erythropoietic activity. When reticulo-




The major cause of resistance to recombinant human
erythropoietin (rHuEPO) is iron deficiency. The percent-
age of hypochromic red blood cells (%HYPO) has been
demonstrated to be the most sensitive and specific
parameter of functional iron deficiency.1 However,
%HYPO is also dependent on erythropoietic activity.2,3
An ideal marker of functional iron deficiency should be
independent of erythropoietic activity, although the
influence of this could be minimized by measuring
mature erythrocyte parameters, excluding the confound-
ing effect of reticulocytes. The aim of this study was to
evaluate mature erythrocyte parameters as markers of
iron deficiency independently of erythropoietic activity. 
Normal values were determined in 57 members of the
nursing staff of the University Hospital of Liège. The
influence of erythropoietic activity was studied in 14
patients with autoimmune hemolytic anemia at the peak
of reticulocytosis. Mature erythrocyte parameters were
validated in 20 patients with iron deficient anemia (IDA),
21 with genetic hemochromatosis, 6 with megaloblastic
anemia due to Biermer’s disease and 11 with heterozy-
gous β-thalassemia.
Red cell parameters were measured with an Advia 120
cell counter (Bayer Diagnostics, Tarrytown, NY, USA).
Parameters are expressed as mean ± standard deviation.
The normal range for all parameters has been determined
as the 95 central percentiles of the distribution (Table 1).
Comparisons between groups were performed using
Student’s t tests. Correlations were calculated with
Spearman’s or Pearson’s coefficient of correlation, as
appropriate.
The mean values and reference ranges established for
the mature erythrocyte population were very similar to
those of the whole red blood cell (RBC) population since
the influence of reticulocytes was negligible (1.0±0.3%
reticulocytes) (Table 1). Compared to the mature erythro-
cyte population, reticulocytes had a 20.1±2.9% greater
mean cell volume (MCV), an 8.7±2.3% greater hemoglo-
bin (Hb) content but a 9.6±1.5% lower Hb concentration.
Similar results have already been published.4 Patients
with AIHA were characterized by high reticulocytosis
(11.6 %) (Table 1). Parameters of the whole RBC popula-
tion showed macrocytic anemia and high %HYPO
(8.1%). Paradoxically, mean cell hemoglobin (MCH) and
mean cell hemoglobin concentration (MCHC) were high
and 60% of the cells had a high Hb content. In the retic-
ulocyte population, 41.6% of the cells were hypochromic
and MCHCr was decreased. However, reticulocytes were
macrocytic and MCHr was high. Only 3.7% of the retic-
ulocytes had a low Hb content. In the mature erythrocyte
population, MCVm was increased to a lower extent than
Table 1. Comparisons between normal subjects and AIHA patients for the whole RBC population, reticulocytes and mature erythrocytes.
Whole population Reticulocytes Mature erythrocytes
Normal AIHA Normal AIHA Normal AIHA
(n=57) (n=14) (n=57) (n=14) (n=57) (n=14)
MCV (fL) 87.0±4.3 99.3±7.2° 106.6±3.3 125.6±12.6° 88.8±4.1 95.5±5.9°
MCH (pg) 29.1±1.6 33.8±3.2° 32.5±0.3 36.4±2.8° 29.9±1.5 33.5±3.3°
MCHC (pg/mL) 33.5±0.9 34.7±2.5* 30.6±0.9 29.2±2.1° 33.8±0.8 35.4±2.6°
%MICRO (%) 0.7±0.5 0.9±0.8 0.1±0.3 0.1±0.2 0.4±0.3 1.0±0.8°
%MACRO (%) 0.7±1.4 13.1±9.6° 6.6±6.4 53.8±27.2° 0.6±1.3 7.4±6.4°
%HYPO (%) 0.9±0.9 8.1±5.5° 15.7±9.0 41.6±22.8° 1.1±0.9 3.4±2.4
%HYPER (%) 0.8±0.7 11.1±11.1° 0.1±0.2 0.4±0.4° 1.3±1.1 12.2±12.3°
%low CH (%) 23.9±10.6 11.1±10.1° 7.6±4.9 3.7±2.8† 24.1±10.6 11.9±10.7°
%high CH (%) 29.6±12.5 60.1±24.1° 55.9±13.3 78.4±16.0° 29.3±12.5 58.0±25.0°
Ferritin (ng/mL) 89.7±73.6 644.6±438.2° − − − −
SI (µmol/L) 18.9±4.3 21.8±10.5 − − − −
RBC (109/µL) 5.03±0.43 2.53±0.62° − − − −
Hb (g/dL) 14.4±1.0 8.6±2.4° − − − −
Retic Hb (mg) 16.8±4.4 102.6±43.2° − − − −
Hct (%) 43.6±2.9 25.4±6.00° − − − −
Retic (106/µL) 51.7±13.4 280.4±111.0° − − − −
Retic (%) 1.0±0.3 11.6±4.6° − − − −
Retic prod index 1.0±0.3 3.4±1.5° − − − −
*p < 0.01; °p < 0.001. Reticulocyte production index (Retic prod index) = [%retic * (Hct patient / Hct reference)] / maturation index. Maturation index is considered
as constant and = 2.
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in the whole or reticulocyte populations, MCHCm was
more increased and %HYPOm was only slightly elevated
(3.4%). Figure 1A shows mature RBC and reticulocyte
parameters in a representative normal subject and an
AIHA patient, respectively. In the AIHA patient, the
whole cell population V/MCH graph shows an upper-left
extension of cell distribution, these abnormal cells thus
being macrocytic and hypochromic. The reticulocyte
V/MCH graph shows that these hypochromic cells are
reticulocytes. The histograms demonstrate that, com-
pared to the reticulocytes from the normal subject, the
AIHA reticulocytes, considered as hypochromic, have an
increased Hb content and an increased volume.
In all other pathological conditions, mature erythro-
cyte parameters were similar to those in the whole ery-
throid population because of the small proportion of
reticulocytes. 
We also examined the relationship between %HYPO
on the one hand and reticulocytes or iron availability on
the other hand, both in the normal population and in
IDA and AIHA. In AIHA, %HYPO was positively corre-
lated with the reticulocyte count (Figure 1B). Moreover,
while %HYPO was high in patients with low serum
iron, it did not correlate with this parameter in any
pathology. Conversely, %HYPOm was not significantly
correlated with the reticulocyte count, even in AIHA.
However, %HYPOm was significantly correlated with
serum iron in the normal population and in AIHA, but
not in IDA (Figure 1C). In conclusion, this is the first
study investigating the possible role of mature erythro-
cyte parameters for monitoring iron status. Reticulo-
cytes had a larger volume and a lower Hb concentration
than did mature erythrocytes. These differences are
responsible for bias in parameter determination in the
whole RBC population in case of stress reticulocytosis.
Mature erythrocyte measurements are capable of
excluding such bias. Moreover, %HYPO was directly
influenced by the reticulocyte count but not by serum
iron whereas %HYPOm was independent of erythro-
poietic activity and correlated well with functional iron
deficiency. This makes %HYPOm a good candidate for
iron monitoring in hemodialysis patients treated with
rHuEPO in whom both functional iron deficiency and
increased erythropoietic activity are encountered, and
even more so at initiation of treatment than in the main-
tenance phase. 
Christophe Bovy, André Gothot, Jean-Marie Krzesinski, Yves Beguin
CHU Sart-Tilman, Belgium
Figure 1. A. Comparison of a
healthy subject (Normal) and a
representative patient with AIHA.
The whole RBC population is
shown in the left panel. An upper
left extension of the V/MCH
graph is observed in AIHA. In the
right panel, the indentification of
reticulocytes (in blue) demon-
strates that the hypochromic
cells in AIHA are reticulocytes. B.
Correlation between %HYPO and
%reticulocytes. There is a signifi-
cant positive correlation in the
case of stress reticulocytosis
(AIHA). C. Correlation between
%HYPOm and serum iron (SI).
%HYPOm correlated negatively
with serum iron in AIHA and the
normal population. This correla-
tion was not significant in IDA
probably because of the small
range of SI values in this disor-
der.
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Red Cell Disorders
A new polyadenylation site mutation associated
with a mild β-thalassemia phenotype 
At least 180,000 autochthonous and allochtho-
nous people are carriers of a large spectrum of
hemoglobinopathies in The Netherlands.1 We
describe two cases, the first, a 33-year old
Surinamese Creole woman, studied because of an
intermediate hemolytic anemia; the second, a cou-
ple requesting analysis because of a previously
diagnosed carrier state in the male partner, while




Hematologic parameters were measured on fresh EDTA
blood on a semiautomatic counter and lysates were exam-
ined on alkaline starch gel electrophoresis. The HbA2 and
HbF levels were estimated by automatic high performance
liquid chromatographic (HPLC) analysis (Variant I and
Variant II, Bio-Rad Laboratories, Hercules, CA, USA).
Biochemical and molecular analyses were done according
to previously described procedures.2-4 Samples were ana-
lyzed on an ABI PrismTM 377 sequencing apparatus
(Applied Biosystems, Perkin Elmer Corporation, Foster
City, Ca, USA). The haplotype of the β-genes was deter-
mined using the following 7 polymorphic sites and restric-
tion enzymes: 1; 5'-ε (Hinc II), 2; Gγ (Hind III), 3; Aγ (Hind
III), 4; Ψβ (Hinc II), 5; 3'- Ψβ (Hinc II), 6; 5'-β‚ (Hinf I), 7;
3'-β (Hinf I) according to Varawalla et al.5 and Sutton et al.6
Family #1. A 33-year old Surinamese woman (II-3), her
mother (I-2) and two older sisters were examined because
of a chronic hypochromic microcytic hemolytic anemia.
The proband (II-3) presented with the parameters of an
intermediate β-thalassemia. Her mother was microcytic
but not anemic with a strongly elevated HbF level (58%).
The proband’s two older sisters had the phenotypes of
heterozygous β-thalassemia (II-1) and of a mild δβ-tha-
lassemia trait with increased HbF level (II-2). The father (I-
1) was not available for examination. Direct sequencing
revealed the –88 (C→T) β+ thalassemia mutation7 and the
new poly A mutation AATAAA→AATATA. These data are
summarized in Table 1.
Family #2. A Surinamese couple was referred for risk
assessment after the male partner had been diagnosed as a
thalassemia carrier. The carrier state of the male was easi-
ly established and confirmed at the molecular level as a
–29 (A→G) mutation in the presence of α+ thalassemia het-
erozygosity. His pregnant partner presented non-tha-
lassemic indices and a normal or a slightly elevated HbA2
level depending on the HPLC system used for measure-
ments. After sequencing the woman was found to be a
carrier of the same poly A mutation previously found in
family #1. The DNA of the fetus showed no thalassemia
mutations. Haplotype analysis revealed that the poly A
mutation was associated with the same haplotype (− − − −
+ + −) in both families (Tables 1 and 2). These data are
summarized in Table 2.
The proband (II-3) in family #1 had an intermediate phe-
notype caused by the β+ -88 C→T and the new polyadeny-
lation site mutation, which destabilizes an otherwise nor-
mal mRNA product. The proband’s mother (I-2) showed a
false homozygous pattern for the -88 mutation, and a very
high HbF expression (58%), without anemia or hemolysis.
A coexisting GγAγ(δβ)0 deletion, called HPFH-2, was con-
firmed (Table 1). 
The routine analysis of the couple (family #2) confirmed
a typical β thalassemia minor phenotype in the man and a
Table 1. Hematologic, biochemical and molecular data in family 1.
Parameters I-1 I-2 II-1 II-2 II-3*
Age/gender ?/M 69/F 50/F 48/F 33/F
Hb (g/dL) n.d. 13.5 13.5 12.6 10.8
PCV (l/L) n.d. 0.40 0.41 0.40 0.34
RBC (1012/L) n.d. 6.25 5.8 4.9 5.7
MCV (fL) n.d. 64 71 80 60
MCH (pg) n.d. 21.6 22.9 25.3 19.0
Hb A2 (%) n.d. 4.6 5.7 2.1 8.56
Hb F (%) n.d. 58 1.2 12 3.6
Osmotic fragility n.d. ↓↓↓ ↓↓↓ ↓↓↓ ↓↓↓
Haptoglobin (mg/dL) n.d. 30 265 76 44
Ferritin (µg/L) n.d. Normal Normal Normal Normal
Inclusion bodies n.d. n.d. n.d. n.d. n.d.
Erythr. morphology n.d. ++ + + +++
ZPP (µmoL/mol heme) n.d. n.d. n.d. n.d. n.d.
β/α synth. ratio n.d. n.d. 0.7 0.6 0.22
Gγ (%) n.d. 54 n.d. 54 n.d.
Aγ (%) n.d. 46 n.d. 46 n.d.
β defect 1 →AATATA δβdel -88 (C→T) δβdel →AATATA
β defect 2 -88 (C→T) -88 (C→T)
β-cluster haplotype
Fragment
1 −/−# +/− +/− −/− +/−
2 −/− −/− −/− −/− −/−
3 −/− −/− −/− −/− −/−
4 −/− −/− −/− −/− −/−
5 +/+ +/+ +/+ +/+ +/+
6 +/+ +/+ +/+ +/+ +/+
7 +/− +/+ +/+ +/+ +/−
*proband; #: deduced; n.d.: not done; +,++,+++: degree of abnormality.
